---
title: "北京昭衍新藥研究中心股份有限公司 (06127.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/06127.HK.md"
symbol: "06127.HK"
name: "北京昭衍新藥研究中心股份有限公司"
industry: "生命科學工具與服務"
---

# 北京昭衍新藥研究中心股份有限公司 (06127.HK)

| Item | Detail |
|------|--------|
| Industry | 生命科學工具與服務 |
| Location | 港股市場 |
| Website | [www.joinnlabs.com](https://www.joinnlabs.com) |

## Company Profile

食品、日用化學產品、化學試劑、生物製品、生物技術的技術開發、技術轉讓、技術咨詢、技術服務、技術培訓;貨物進出口、技術進出口、代理進出口;技術檢測。

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-21T04:30:11.000Z

**Overall: C (0.53)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 9 / 14 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -22.29% |  |
| Net Profit YoY | 24505.09% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.82 |  |
| Dividend Ratio | 0.15% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 16.20B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 1.80B |  |


**Multi Score**: C

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 2.79% | C |
| Profit Margin | 13.49% | B |
| Gross Margin | 33.88% | C |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -22.29% | E |
| Net Profit YoY | 24505.09% | A |
| Total Assets YoY | -1.29% | D |
| Net Assets YoY | 0.23% | C |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 741.10% | B |
| OCF YoY | -22.29% | E |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.18 | D |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 14.81% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 北京昭衍新藥研究中心股份有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "2.79%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "13.49%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "33.88%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-22.29%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "24505.09%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-1.29%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "0.23%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "741.10%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "-22.29%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.18",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "14.81%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 藥明康德 (HK.2359) | A | A | C | B | B | B |
| 02 | 藥明生物 (HK.2269) | B | B | D | A | B | B |
| 03 | 藥明合聯 (HK.2268) | A | A | B | B | B | B |
| 04 | 晶泰控股 (HK.2228) | D | A | E | A | C | B |
| 05 | 康龍化成 (HK.3759) | B | B | C | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 65.71 | 10/15 | 68.20 | 50.15 | 31.06 |
| PB | 1.82 | 7/15 | 1.92 | 1.66 | 1.20 |
| PS (TTM) | 8.87 | 12/15 | 8.80 | 7.29 | 4.68 |
| Dividend Yield | 0.15% | 4/15 | 1.28% | 0.17% | 0.14% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-21T16:00:00.000Z

Total Analysts: **5**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 40% |
| Overweight | 0 | 0% |
| Hold | 2 | 40% |
| Underweight | 1 | 20% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 21.62 |
| Highest Target | 28.68 |
| Lowest Target | 6.86 |

## References

- [Company Overview](https://longbridge.com/en/quote/06127.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/06127.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/06127.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.